+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lymph node ratio, an independent prognostic factor for patients with stage II-III rectal carcinoma



Lymph node ratio, an independent prognostic factor for patients with stage II-III rectal carcinoma



Pathology Research and Practice 215(6): 152384



Identification of the proper surgical method and the most reliable prognostic parameters of rectal carcinomas is a challenging issue. The aim of this paper was to determine the possible prognostic role of the number of harvested lymph nodes versus lymph node ratio (LNR) in patients with rectal carcinomas, and the proper value of LNR that can be used as prognostic parameter. A retrospective study was performed in 186 consecutive patients with rectal carcinomas that underwent surgical resection. The LNR was calculated for cases from stage II-III, and was correlated with classic prognostic parameters and overall survival (OS). A statistically significant difference was found between LNR of 0.15 and OS (p = 0.03), respectively LNR > 0.15 and TNM stage (p < 0.0001), but also tumor infiltration level (p < 0.05). The number of harvested lymph nodes was not correlated with the tumor stage (r = 0.148, p = 0.06) and this parameter did not influence the OS, when the number of 12 or 14 lymph nodes was used as the ideal value (p = 0.6 and p = 0.66, respectively). In patients with rectal carcinomas that underwent preoperative chemoradiotherapy, a LNR of 0.15 is a parameter with independent prognostic value, comparing with the number of harvested lymph nodes. The specific LNR should be calculated in larger cohorts.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066624384

Download citation: RISBibTeXText

PMID: 30910253

DOI: 10.1016/j.prp.2019.03.013


Related references

Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. American Journal of Surgery 207(6): 824-831, 2014

Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection. Asian Pacific Journal of Cancer Prevention 15(13): 5365-5369, 2014

Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. Journal of Surgical Oncology 105(1): 15-20, 2012

Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. European Journal of Surgical Oncology 38(6): 478-483, 2012

Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. International Journal of Radiation Oncology Biology Physics 74(3): 796-802, 2009

The lymph node ratio as prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision and postoperative chemoradiotherapy. Journal of Clinical Oncology 26(15_Suppl): 15003-15003, 2016

Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East. World Journal of Surgical Oncology 10: 63, 2012

Lymph Node Ratio: Is It an Independent Prognostic Factor for Stage III Cutaneous Melanoma?. Asian Pacific Journal of Cancer Prevention 19(12): 3623-3627, 2018

Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta-analysis. Journal of Evidence-Based Medicine 11(3): 169-175, 2018

Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. Journal of the American College of Surgeons 211(2): 196-204, 2010

Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer. Zhonghua Zhong Liu Za Zhi 34(7): 506-509, 2012

Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue?. Gulf Journal of Oncology 1(28): 6, 2018

Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head and Neck 33(9): 1245-1251, 2011

The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cellular Oncology 29(5): 387-398, 2007

Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. International Journal of Colorectal Disease 26(7): 891-896, 2011